BioLife Sciences Inc.
BLFE · OTC
11/30/2020 | 11/30/2019 | 11/30/2018 | 11/30/2017 | |
|---|---|---|---|---|
| Market Cap | $59 | $46 | $46 | $10 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $59 | $46 | $46 | $11 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | $0 | $0 | $0 |
| % Margin | -239.3% | – | – | – |
| EBITDA | -$1 | $0 | -$0 | -$0 |
| % Margin | -295.9% | – | – | – |
| Net Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | -308% | – | – | – |
| EPS Diluted | -0.025 | -0 | -0.003 | -0.077 |
| % Growth | -24,400% | 96.3% | 96.5% | – |
| Operating Cash Flow | -$1 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | $0 | -$0 | -$0 |